acyclovir
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
72578-002 -
Package NDC
72578-002-01 -
Package NDC
72578-002-05 -
Package NDC
72578-002-06 -
Package NDC
72578-002-10 -
Package NDC
72578-002-16 -
Application number
ANDA204313 -
SPL ID
b797bf2f-d83c-413a-90bf-63c3a0eabf89 -
SPL set ID
e580b7e9-9060-43f5-9b58-33998078d7e4 -
UNII
X4HES1O11F -
RxCUI
197310
What the source publishes
- Labeler
- Viona Pharmaceuticals Inc
- Active ingredients
- acyclovir
- Form
- CAPSULE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "acyclovir",
"splId": "b797bf2f-d83c-413a-90bf-63c3a0eabf89",
"labels": [
{
"setId": "e580b7e9-9060-43f5-9b58-33998078d7e4",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e580b7e9-9060-43f5-9b58-33998078d7e4",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e580b7e9-9060-43f5-9b58-33998078d7e4"
}
],
"routes": [
"ORAL"
],
"labeler": "Viona Pharmaceuticals Inc",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 CAPSULE in 1 BOTTLE (72578-002-01)",
"package_ndc": "72578-002-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20190823"
},
{
"sample": false,
"description": "500 CAPSULE in 1 BOTTLE (72578-002-05)",
"package_ndc": "72578-002-05",
"identifierStatus": "well-formed",
"marketing_start_date": "20190823"
},
{
"sample": false,
"description": "30 CAPSULE in 1 BOTTLE (72578-002-06)",
"package_ndc": "72578-002-06",
"identifierStatus": "well-formed",
"marketing_start_date": "20190823"
},
{
"sample": false,
"description": "1000 CAPSULE in 1 BOTTLE (72578-002-10)",
"package_ndc": "72578-002-10",
"identifierStatus": "well-formed",
"marketing_start_date": "20190823"
},
{
"sample": false,
"description": "90 CAPSULE in 1 BOTTLE (72578-002-16)",
"package_ndc": "72578-002-16",
"identifierStatus": "well-formed",
"marketing_start_date": "20190823"
}
],
"productId": "72578-002_b797bf2f-d83c-413a-90bf-63c3a0eabf89",
"useDomain": "unknown",
"dosageForm": "CAPSULE",
"productNdc": "72578-002",
"deaSchedule": null,
"genericName": "acyclovir",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "ACYCLOVIR",
"strength": "200 mg/1"
}
],
"applicationNumber": "ANDA204313",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20190823",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000020060",
"N0000180187",
"N0000180188",
"N0000175468",
"N0000175459"
],
"unii": [
"X4HES1O11F"
],
"rxcui": [
"197310"
],
"spl_set_id": [
"e580b7e9-9060-43f5-9b58-33998078d7e4"
],
"pharm_class_epc": [
"Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]",
"Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]",
"Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"
],
"pharm_class_moa": [
"DNA Polymerase Inhibitors [MoA]"
],
"manufacturer_name": [
"Viona Pharmaceuticals Inc"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:72578-002_b797bf2f-d83c-413a-90bf-63c3a0eabf89"